Menu Search
Equities

Shionogi & Co Ltd

4507:TYO

Shionogi & Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,094.50
  • Today's Change35.50 / 1.72%
  • Shares traded1.63m
  • 1 Year change-9.82%
  • Beta0.7661
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income198,283220,332126,268
Depreciation/depletion18,32317,16516,351
Non-Cash items(36604)(59703)(15456)
Cash taxes paid, supplemental63,63727,28426,038
Cash interest paid, supplemental1649487
Changes in working capital(25717)72(25095)
Total cash from operations154,285177,866102,068
INVESTING
Capital expenditures(28267)(37187)(31564)
Other investing and cash flow items, total34,189(11105)(64640)
Total cash from investing5,922(48292)(96204)
FINANCING
Financing cash flow items(4715)4,716(2)
Total cash dividends paid(43876)(36142)(33146)
Issuance (retirement) of stock, net(75182)(49539)(14)
Issuance (retirement) of debt, net(3080)(3158)(3453)
Total cash from financing(126853)(84123)(36615)
NET CHANGE IN CASH
Foreign exchange effects15,5129,3528,998
Net change in cash48,86654,803(21753)
Net cash-begin balance/reserved for future use309,224254,420276,173
Net cash-end balance/reserved for future use358,090309,224254,420
SUPPLEMENTAL INCOME
Depreciation, supplemental18,32317,16516,351
Cash interest paid, supplemental1649487
Cash taxes paid, supplemental63,63727,28426,038
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.